Keay Nakae
Stock Analyst at Chardan Capital
(4.44)
# 312
Out of 5,090 analysts
251
Total ratings
46.09%
Success rate
26.91%
Average return
Main Sectors:
Stocks Rated by Keay Nakae
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARWR Arrowhead Pharmaceuticals | Maintains: Buy | $60 | $61.43 | -2.32% | 22 | Dec 1, 2025 | |
| ALUR Allurion Technologies | Maintains: Neutral | $2.5 | $1.70 | +47.49% | 7 | Nov 20, 2025 | |
| SABS SAB Biotherapeutics | Maintains: Buy | $12 | $3.99 | +200.75% | 18 | Nov 17, 2025 | |
| ABUS Arbutus Biopharma | Maintains: Buy | $5 | $4.45 | +12.49% | 14 | Nov 14, 2025 | |
| COYA Coya Therapeutics | Maintains: Buy | $14 | $6.00 | +133.33% | 22 | Nov 14, 2025 | |
| MNPR Monopar Therapeutics | Maintains: Buy | $100 | $81.34 | +22.95% | 6 | Nov 13, 2025 | |
| OBIO Orchestra BioMed Holdings | Maintains: Buy | $20 | $4.41 | +353.51% | 13 | Nov 13, 2025 | |
| KRRO Korro Bio | Downgrades: Neutral | $25 → $7 | $7.02 | -0.28% | 4 | Nov 13, 2025 | |
| RNA Avidity Biosciences | Maintains: Neutral | $72 | $71.76 | +0.33% | 21 | Nov 11, 2025 | |
| PRQR ProQR Therapeutics | Maintains: Buy | $4 | $2.08 | +92.31% | 16 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 | $6.98 | +401.43% | 13 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $325 → $400 | $458.55 | -12.77% | 14 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $38 | $20.27 | +87.47% | 13 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 | $1.20 | +316.67% | 5 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $1.25 → $6 | $16.59 | -63.83% | 10 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 | $3.82 | +57.07% | 7 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $0.88 | +808.16% | 10 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.12 | - | 5 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $8 → $6 | $17.94 | -66.56% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,140 → $380 | $5.15 | +7,278.64% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $55 | $11.87 | +363.35% | 10 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.25 → $10 | $4.98 | +100.80% | 5 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $100 → $88 | $20.00 | +337.50% | 2 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $0.7 → $13 | $1.23 | +961.22% | 3 | Feb 9, 2021 |
Arrowhead Pharmaceuticals
Dec 1, 2025
Maintains: Buy
Price Target: $60
Current: $61.43
Upside: -2.32%
Allurion Technologies
Nov 20, 2025
Maintains: Neutral
Price Target: $2.5
Current: $1.70
Upside: +47.49%
SAB Biotherapeutics
Nov 17, 2025
Maintains: Buy
Price Target: $12
Current: $3.99
Upside: +200.75%
Arbutus Biopharma
Nov 14, 2025
Maintains: Buy
Price Target: $5
Current: $4.45
Upside: +12.49%
Coya Therapeutics
Nov 14, 2025
Maintains: Buy
Price Target: $14
Current: $6.00
Upside: +133.33%
Monopar Therapeutics
Nov 13, 2025
Maintains: Buy
Price Target: $100
Current: $81.34
Upside: +22.95%
Orchestra BioMed Holdings
Nov 13, 2025
Maintains: Buy
Price Target: $20
Current: $4.41
Upside: +353.51%
Korro Bio
Nov 13, 2025
Downgrades: Neutral
Price Target: $25 → $7
Current: $7.02
Upside: -0.28%
Avidity Biosciences
Nov 11, 2025
Maintains: Neutral
Price Target: $72
Current: $71.76
Upside: +0.33%
ProQR Therapeutics
Nov 4, 2025
Maintains: Buy
Price Target: $4
Current: $2.08
Upside: +92.31%
Aug 8, 2025
Maintains: Buy
Price Target: $35
Current: $6.98
Upside: +401.43%
Aug 1, 2025
Maintains: Buy
Price Target: $325 → $400
Current: $458.55
Upside: -12.77%
Jul 29, 2025
Maintains: Buy
Price Target: $50 → $38
Current: $20.27
Upside: +87.47%
Jun 25, 2025
Maintains: Buy
Price Target: $5
Current: $1.20
Upside: +316.67%
May 8, 2025
Downgrades: Neutral
Price Target: $1.25 → $6
Current: $16.59
Upside: -63.83%
Mar 28, 2025
Maintains: Buy
Price Target: $6
Current: $3.82
Upside: +57.07%
Nov 13, 2024
Maintains: Buy
Price Target: $10 → $8
Current: $0.88
Upside: +808.16%
Feb 9, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.12
Upside: -
Aug 4, 2023
Maintains: Sell
Price Target: $8 → $6
Current: $17.94
Upside: -66.56%
Nov 10, 2022
Maintains: Buy
Price Target: $1,140 → $380
Current: $5.15
Upside: +7,278.64%
Nov 9, 2022
Maintains: Buy
Price Target: $65 → $55
Current: $11.87
Upside: +363.35%
Aug 16, 2022
Maintains: Neutral
Price Target: $1.25 → $10
Current: $4.98
Upside: +100.80%
Sep 20, 2021
Upgrades: Neutral
Price Target: $100 → $88
Current: $20.00
Upside: +337.50%
Feb 9, 2021
Downgrades: Neutral
Price Target: $0.7 → $13
Current: $1.23
Upside: +961.22%